@article{ATM26057,
author = {Benedikt Schoser},
title = {Pompe disease: what are we missing?},
journal = {Annals of Translational Medicine},
volume = {7},
number = {13},
year = {2019},
keywords = {},
abstract = {Pompe disease is a multisystemic metabolic disorder caused by a deficiency of lysosomal acid alpha-glucosidase (GAA) leading to progressive accumulation of lysosomal glycogen, lysosomal swelling and rupture in all tissues of the human body. Furthermore, autophagic buildup, organelle abnormalities, and energy deficit are regularly observed. Enzyme replacement therapy has been available for patients living with Pompe disease for more than 15 years. Although our disease knowledge has grown enormously, we still have multiple challenges to overcome. Here, I will discuss unmet clinical needs, neglected or overlooked aspects of the pathophysiology, and issues related to future therapies.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/26057}
}